【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 17
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 18
3 Disease Overview 19
3.1 Etiology and Pathophysiology 19
3.1.1 Etiology 19
3.1.2 Pathophysiology 20
3.2 Symptoms 22
3.3 Diagnosis 22
3.4 Prognosis 23
3.5 Quality of Life 23
4 Epidemiology 25
4.1 Disease Background 25
4.1.1 GHD in Children 25
4.1.2 GHD in Adults 26
4.2 Risk Factors and Comorbidities 26
4.3 Global Trends 28
4.3.1 GHD in Children 29
4.3.2 GHD in Adults 31
4.4 Forecast Methodology 32
4.4.1 Sources Used 36
4.4.1.1 7MM 36
4.4.1.2 Diagnosed Cases of GHD in Children 37
4.4.1.3 Diagnosed Cases of GHD in Adults 38
4.4.1.4 GHD Etiological Classification in Children 38
4.4.1.5 GHD Etiological Classification in Adults 39
4.4.2 Sources Not Used 40
4.4.3 Forecast Assumptions and Methods 41
4.4.3.1 Temporal Trends 41
4.4.3.2 Sex-Specific Trends 41
4.4.3.3 Diagnosed Prevalent Cases of GHD in Children 41
4.4.3.4 Diagnosed Prevalent Cases of GHD in Adults 42
4.4.3.5 GHD Etiological Classification in Children 43
4.4.3.6 GHD Etiological Classification in Adults 43
4.5 Epidemiological Forecast of GHD (2014-2024) 44
4.5.1 Diagnosed Prevalent Cases of GHD 44
4.5.2 Diagnosed Prevalent Cases of GHD by Sex 46
4.5.3 Diagnosed Prevalent Cases of GHD by Age 47
4.5.3.1 Diagnosed Prevalent Cases of GHD in Children 47
4.5.3.2 Diagnosed Prevalent Cases of GHD in Adults 49
4.5.4 Age-Adjusted Diagnosed Prevalence of GHD 50
4.5.5 Diagnosed Prevalent Cases of GHD in Children by Etiological Classification 51
4.5.6 Diagnosed Prevalent Cases of GHD in Adults by Etiological Classification 52
4.6 Discussion 53
4.6.1 Epidemiological Forecast Insight 53
4.6.2 Limitations of the Analysis 54
4.6.3 Strengths of the Analysis 55
5 Competitive Assessment 56
5.1 Overview 56
5.2 Treatment Algorithm 56
5.3 Market Access, Reimbursement, and Clinical Practice 58
5.4 Product Profiles — Recombinant Human Growth Hormones 60
5.4.1 Overview 60
5.4.1.1 Genotropin 61
5.4.1.2 Humatrope 62
5.4.1.3 Norditropin 62
5.4.1.4 Nutropin AQ 63
5.4.1.5 Saizen 64
5.4.1.6 Tev-Tropin/Zomacton/Growject 64
5.4.1.7 Omnitrope Biosimilar 65
5.4.2 Efficacy 68
5.4.2.1 Pediatric GHD 68
5.4.2.2 Adult GHD 68
5.4.3 Safety 69
5.4.3.1 Pediatric GHD 69
5.4.3.2 Adult GHD 69
5.4.4 SWOT Analysis 70
6 Unmet Needs Assessment and Opportunity Analysis 71
6.1 Overview 71
6.2 Improved Adherence and Compliance 72
6.2.1 Unmet Needs 72
6.2.2 Gap Analysis 74
6.2.3 Opportunity 74
6.3 Early Diagnosis 75
6.3.1 Unmet Needs 75
6.3.2 Gap Analysis 75
6.3.3 Opportunity 76
6.4 Disease Awareness and Regulatory Policy in Japan 76
6.4.1 Unmet Needs 76
6.4.2 Gap Analysis 77
6.4.3 Opportunity 77
6.5 Insurance Policies that Impact Patient Access 78
6.5.1 Unmet Needs 78
6.5.2 Gap Analysis 79
6.5.3 Opportunity Analysis 79
6.6 Safer Treatments for Cancer Survivors 79
6.6.1 Unmet needs 79
6.6.2 Gap Analysis 80
6.6.3 Opportunity Analysis 80
7 R&D Strategies 81
7.1 Overview 81
7.1.1 Development of Long-Acting Biobetter Growth Hormones 81
7.1.2 Novel Drug Delivery Strategies 82
7.1.3 Targeting the Growth Hormone Releasing Hormone 83
7.1.4 Licensing and Acquisitions 83
7.2 Clinical Trial Design 84
7.2.1 Current Clinical Trial Design 84
7.2.2 Future Clinical Trial Design 85
8 Pipeline Assessment 88
8.1 Overview 88
8.2 Promising Drugs in Clinical Development 89
8.2.1 Somatropin Biopartners 91
8.2.1.1 Overview 91
8.2.1.2 Efficacy 92
8.2.1.3 Safety 92
8.2.1.4 SWOT Analysis 93
8.2.2 NNC0195-0092 93
8.2.2.1 Overview 93
8.2.2.2 Efficacy 95
8.2.2.3 Safety 95
8.2.2.4 SWOT Analysis 95
8.2.3 MOD-4023 96
8.2.3.1 Overview 96
8.2.3.2 Efficacy 97
8.2.3.3 Safety 97
8.2.3.4 SWOT Analysis 98
8.2.4 VRS-317 98
8.2.4.1 Overview 98
8.2.4.2 Efficacy 99
8.2.4.3 Safety 99
8.2.4.4 SWOT Analysis 100
8.2.5 ACP-001 100
8.2.5.1 Overview 100
8.2.5.2 Efficacy 101
8.2.5.3 Safety 101
8.2.5.4 SWOT Analysis 102
8.2.6 TV-1106 102
8.2.6.1 Overview 102
8.2.6.2 Efficacy 103
8.2.6.3 Safety 103
8.2.6.4 SWOT Analysis 104
8.3 Innovative Early-Stage Approaches 104
9 Pipeline Valuation Analysis 107
9.1 Clinical Benchmark of Key Pipeline Drugs 107
9.2 Commercial Benchmark of Key Pipeline Drugs 109
9.3 Competitive Assessment 112
9.4 Top Line Ten Year Forecast 113
9.4.1 US 118
9.4.2 5EU 119
9.4.3 Japan 120
10 Appendix 122
10.1 Bibliography 122
10.2 Abbreviations 130
10.3 Methodology 133
10.4 Forecasting Methodology 133
10.4.1 Diagnosed GHD patients 133
10.4.2 Percent Drug-Treated Patients 133
10.4.3 Drugs Included in Each Therapeutic Class 134
10.4.4 Launch and Patent Expiry Dates 134
10.4.5 General Pricing Assumptions 135
10.4.6 Individual Drug Assumptions 136
10.4.7 Pricing of Pipeline agents 139
10.5 Physicians Included in This Study 141
10.6 Payers Included in This Study 142
10.7 Primary Research – Prescriber Survey 143
10.8 About the Authors 144
10.8.1 Analyst 144
10.8.2 Epidemiologist 144
10.8.3 Therapy Director – CVMD 145
10.8.4 Global Head of Healthcare 145
10.9 About GlobalData 146
10.10 Disclaimer 146
【レポート販売概要】
■ タイトル:成長ホルモン分泌不全症治療薬の世界市場機会分析■ 英文:OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024
■ 発行日:2015年8月1日
■ 調査会社:GlobalData
■ 商品コード:GDHC029POA
■ 調査対象地域:グローバル
- エンタプライズSSDの世界市場2016-2020About Enterprise SSD A SSD is a solid state disk or an electronic disk that is used for data storage and built out of semiconductors. It uses the same input/output interface design as hard disk drives (HDDs) and stores data electronically in a solid state memory. It is made out of silicon microchips and use DRAM or NAND-based flash memory to store data. Flash-based SSDs do not require batteries, a …
- アルミニウム箔パッケージングの世界市場2016-2020About Aluminum Foils Aluminum foils are produced by continuous casting and cold rolling of aluminum sheets. They are prepared in thin metal leaves and can be used to wrap around any product for packaging. They act as a major barrier to bacteria, oxygen, and moisture. These are used in the pharmaceutical and food and beverage sectors. Technavio’s analysts forecast the global aluminium foil packagin …
- 指向性掘削の世界市場2015-2019About directional drilling Directional drilling is a practice of controlling the deviation and direction of a wellbore in order to access the predetermined target zone. The major application of directional drilling are mentioned below: • Horizontal well drilling • Multilateral well drilling • Extended reach drilling The global directional drilling market is expected to witness steady growth in the …
- 2014 Assessments of Leading Transfusion Diagnostic Testing Market Players–Strategic Analyses of Major Suppliers and Emerging Market EntrantsThis new report from Venture Planning Group provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: SalesProduct portfoliosMarketing tacticsTechnological know-howNew products in R&DCollaborative arrangementsBusiness strategiesContains 50 pages
- フレキシブルエポキシ樹脂の世界市場予測(~2022年):ウレタン変性、ゴム変性、ダイマー酸The flexible epoxy resin (FER) market is estimated at USD 570.9 Million in 2017 and is projected to reach USD 764.0 Million by 2022, at a CAGR of 6.0% between 2017 and 2022. The growth is driven by the increasing demand for FERs from the end-use industries such as automotive and building & construction. These end-use industries have a high consumption of paints & coatings, composites, and adhesive …
- 世界における大腸がん検査製品のパイプライン動向2015Colorectal Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer - Pipeline Review, 2015" provides an overview of Colorectal Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major pl …
- 神経因性疼痛:グローバル臨床試験レビュー(2014年上半期)Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathic Pain. It includes an overview of the trial numbers and their recruitment statu …
- (S)-(+)-アブシシン酸の世界市場2015(S)-(+)-Abscisic acid (CAS 21293-29-8) Market Research Report 2015 aims at providing comprehensive data on (S)-(+)-Abscisic acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes (S)-(+)-Abscisic acid description, covers its application areas, manufacturing methods, patterns. It captures (S)-(+)-Abscisic acid market trends, pays close attention to …
- 米国の熱源供給システム分析:Analyzing Combined Heat and Power in the USCombined heat and power (CHP) or cogeneration is the use of a heat engine or a power station to simultaneously generate both electricity and useful heat. Conventional power plants emit the heat created as a by-product of electricity generation into the environment through cooling towers, flue gas, or by other means. CHP or a bottoming cycle captures the by-product heat for domestic or industrial h …
- デジタルレンディングプラットフォームの世界市場予測(~2023年)Growing adoption of digital technologies with an increasing use of smartphones for banking applications to drive the digital lending platform marketThe global digital lending platform market size is expected to grow from USD 5.1 billion in 2018 to USD 12.1 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 18.7% during the forecast period. Major growth factors for the market include proli …
- 採血製品の世界市場:採血シリンジ、採血針、EDTA、ヘパリン、血清、採血管、血液ランセット、血液バッグThe blood collection market is expected to reach USD 9.90 Billion by 2021 from USD 7.65 Billion in 2016, at CAGR of 5.3% in the forecast period. Factors driving the market include rising incidences of diseases, increasing number of surgeries, and growing number of accidental and trauma cases. However, the risks associated with blood transfusions in underdeveloped regions is expected to restrain th …
- IoT(モノのインターネット)通信プロトコルの世界市場予測(~2022)According to the MarketsandMarkets forecast, the IoT communication protocol market, in terms of value, is expected to grow from USD 11.44 Billion in 2015 to USD 15.80 Billion by 2022, at a CAGR of 4.7% between 2016 and 2022. The market is highly diversified and competitive with market players that include top-tier and mid-tier companies and as well as start-up firms. With the rate of proliferation …
- NigeriaのBitumen and Asphalt, Natural市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Nigeria and its perspectives on the global market for bitumen and asphalt, natural. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on bitumen and asphalt, natural export/import operations in Nigeria. The 2002-201 …
- 感染予防対策の世界市場:消毒製品(内視鏡洗浄機、殺菌剤、消毒薬)、殺菌技術(加熱殺菌、低温殺菌、ろ過殺菌、電離放射線殺菌)Sterilization and disinfection are essential components of infection control procedures. New technologies like E-beam and gamma are poised to garner strong market shares in the future, due to their greater product compatibility and low prices. These technologies have been beneficial for medical packaging, food irradiation, medical disposables, and microbiological equipment sterilization. In this r …
- ポリシリコンの世界市場分析:技術別、用途別(太陽光発電、電子)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ)、動向・動態、競争戦略、セグメント予測、2014-2025The global polysilicon market is anticipated to reach USD 13.56 billion by 2025, according to a new report by Grand View Research, Inc. The growing solar PV (photovoltaic) and electronic industry are expected to propel market demand over the coming years. The FBR technology used in the production of polysilicon has helped to reduce manufacturing cost to a large extent, thus lowering prices of poly …